High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain

被引:78
作者
Ruiz, M.
Marti, S.
Fernandez-Cuenca, F.
Pascual, A.
Vila, J. [1 ]
机构
[1] Univ Barcelona, Fac Med, Hosp Clin, Ctr Diagnost Biomed,Serv Microbiol,IDIBAPS, Barcelona 7, Spain
[2] Hosp Virgen Macarena, Microbiol Serv, Seville, Spain
关键词
Acinetobacter baumannii; carbapenemase; expression; ISAba1; oxacillinase; resistance;
D O I
10.1111/j.1469-0691.2007.01825.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Carbapenem-hydrolysing oxacillinases are reported increasingly in Acinetobacter baumannii. This study investigated the role of these beta-lactamases in causing resistance to carbapenems in 83 epidemiologically related and unrelated imipenem-resistant A. baumannii clinical isolates. The isolates were also analysed for the presence of ISAba1 in the promoter region of the bla(OXA-51)-like gene in order to investigate the role of ISAba1 in OXA-51 expression. All clinical isolates contained a bla(OXA-51)-like gene, 20% contained a bla(OXA-58)-like gene, and 42% contained a bla(OXA-40)-like gene; bla(OXA-23)-like, bla(IMP) and bla(VIM) genes were not detected in any of the isolates investigated. ISAba1 was found in 24 (82.7%) of 28 pulsetypes, and was located in the promoter region of the bla(OXA-51)-like gene in five (20.8%) of these pulsetypes. Expression of bla(OXA-51) was detected in the five isolates with ISAba1 located in the promoter region, but was not detected in an isogenic imipenem-susceptible A. baumannii isolate that did not have ISAba1 located in the promoter region. It was concluded that there is a high prevalence of oxacillinases with activity against carbapenems among genetically unrelated A. baumannii clinical isolates from Spain, and that concomitant expression of two carbapenemases (OXA-51-like and either OXA-40-like or OXA-58-like) may take place. Insertion of an ISAba1-like element in the promoter of the bla(OXA-51)-like gene promotes the expression of this gene, although this did not seem to play a major role in carbapenem resistance.
引用
收藏
页码:1192 / 1198
页数:7
相关论文
共 42 条
[1]   Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].
Afzal-Shah, M ;
Woodford, N ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :583-588
[2]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[3]   OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain [J].
Bou, G ;
Oliver, A ;
Martínez-Beltran, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1556-1561
[4]   The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents [J].
Brown, S ;
Amyes, SGB .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (04) :326-329
[5]   Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina [J].
Brown, S ;
Young, HK ;
Amyes, SGB .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (01) :15-23
[6]   IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998 [J].
Chu, YW ;
Afzal-Shah, M ;
Houang, ETS ;
Palepou, MFI ;
Lyon, DJ ;
Woodford, N ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :710-714
[7]   Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain:: a nationwide study [J].
Cisneros, JM ;
Rodríguez-Baño, J ;
Fernández-Cuenca, F ;
Ribera, A ;
Vila, J ;
Pascual, A ;
Martínez-Martínez, L ;
Bou, G ;
Pachón, J .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (11) :874-879
[8]   Imipenem resistance among Acinetobacter baumannii: Association with reduced expression of a 33-36 kDa outer membrane protein [J].
Clark, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) :245-251
[9]  
*CLIN LAB STAND I, 2005, M100515 CLSI
[10]   Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents [J].
Coelho, J ;
Woodford, N ;
Afzal-Shah, M ;
Livermore, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :756-758